15 New IPOs Scheduled for Week of June 23

Francis Gaskins  |

The complete calendar is at IPOpremium.com

Ranked in size of IPO

(1) Based in Memphis, TN, ServiceMaster Global Holdings ($SERV) scheduled a $700 million IPO on the NYSE with a market capitalization of $2.5 billion at a price range midpoint of $19.50 for Thursday, June 26, 2014.

SERV is a stable consumer services-oriented business with top line revenue growth around 3.5% annually. Customer retention rates are high.

(2) Based in Irving, TX, The Michaels Companies ($MIK) scheduled a $500 million IPO on the Nasdaq with a market capitalization of $4.6 billion at a price range midpoint of $18 for Friday, June 27, 2014.

MIK is a large arts and crafts specialty retailer

(3) Based in San Mateo, CA, GoPro ($GPRO) scheduled a $400 million IPO on the Nasdaq with a market capitalization of $2.8 billion at a price range midpoint of $22.50 for Thursday, June 26, 2014.

GPRO is fast growing with an established wearable HD camera brand, protected by a number of patents.

(4) Based in Juno Beach, FL, NextEra Energy Partners, LP ($NEP) scheduled a $325 million IPO on the NYSE with a market capitalization of $1.52 billion at a price range midpoint of $20 for Friday, June 27, 2014.

NEP is a growth-oriented limited partnership formed by NextEra Energy, Inc. to own, operate and acquire contracted clean energy projects with stable, long-term cash flows through its limited partner interest in NEE Operating LP.

(5) Based in Leuven, Belgium, Materialise NV ($MTLS) scheduled a $104 million IPO on the Nasdaq with a market capitalization of $612 million at a price range midpoint of $13 for Wednesday, June 25, 2014.

MTLS is a leading provider of additive manufacturing software and of sophisticated 3D printing services. MTLS is a service bureau, a company which provides business services for a fee.

(6) Based in Cham, Switzerland, TCP International Holdings Ltd. ($TCPI) scheduled a $100 million IPO on the Nasdaq with a market capitalization of $440 million at a price range midpoint of $14 for Thursday, June 26, 2014.

TCPI is a leading global provider of energy efficient LED and CFL (compact fluorescent lamplighting) technologies.

(7) Based in Lewisville, TX, Adeptus Health ($ADPT) scheduled a $100 million IPO on the NYSE with a market capitalization of $424 million at a price range midpoint of $20.50 for Wednesday, June 25, 2014.

ADPT owns and operates First Choice Emergency Rooms, the largest network of independent freestanding emergency rooms in the United States.

(8) Based in Rancho Cucamonga, CA, Amphastar Pharmaceuticals ($AMPH) scheduled an $81 million IPO on the Nasdaq with a market capitalization of $470 million at a price range midpoint of $11 for Wednesday, June 25, 2014.

AMPH currently manufactures and sells 15 products in the U.S. and is developing a portfolio of 13 generic and seven proprietary injectable and inhalation product candidates.

(9) Based in Lexington, MA, Imprivata ($IMPR) scheduled a $75 million IPO on the NYSE with a market capitalization of $342 million at a price range midpoint of $15 for Wednesday, June 25, 2014.

IMPR is a leading provider of authentication and access management technology solutions for the healthcare industry.

(10) Based in Shenzhen, China, Xunlei Limited ($XNET) scheduled a $73 million IPO on the Nasdaq with a market capitalization of $694 million at a price range midpoint of $10 for Tuesday, June 24, 2014.

XNET is one of the top 10 largest Chinese internet companies, as measured by user base.

 (11) Based in La Jolla, CA, Ambrx ($AMBX) scheduled a $70 million IPO on the Nasdaq with a market capitalization of $223 million at a price range midpoint of $13 for Wednesday, June 25, 2014.

AMBX is a clinical stage biotechnology company focused on discovering and developing first-in-class and best-in-class optimized protein therapeutics known as bio-conjugates.

(12) Based in Cambridge, MA, Minerva Neurosciences ($NERV) scheduled a $69 million IPO on the Nasdaq with a market capitalization of $186 million at a price range midpoint of $11 for the week of June 23, 2014.

NERV is a clinical-stage biopharmaceutical company focused on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system, or CNS, diseases.

(13) Based in Kennewick, WA, Taggares Agriculture ($TAG) scheduled a $46 million IPO on the Nasdaq with a market capitalization of $54 million at a price range midpoint of $6.50 for the week of June 23, 2014.

TAG was formed in January 2014 to leverage the well-established Taggares family name and farming expertise to acquire, re-develop and operate profitable farmland in the Pacific Northwest (the region encompassing Washington, Oregon and Idaho).

(14) Based in Emeryville, CA, KineMed ($KNMD) scheduled a $31 million IPO on the Nasdaq with a market capitalization of $114 million at a price range midpoint of $7 for the week of June 23, 2014.

KNMD is a revenue-generating health technology company that has developed a proprietary biomarker platform technology with numerous applications in drug development and medical diagnostics.

(15) Based in Louisville, CO, GlobeImmune (GBIM) scheduled a $25 million IPO on the Nasdaq with a market capitalization of $82 million at a price range midpoint of $16 for Friday, June 27, 2014.

GBIM is a biopharmaceutical company established in 1995 focused on developing products for the treatment of cancer and infectious diseases based on its proprietary Tarmogen® platform.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not necessarily represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer.

Trending Articles

Bond Yields Have Risen Well Above Stock Dividend Yields. Are They a Buy?
We're at the Tail End of a Classic Video Game Stock Bust
Is Gold Really the Right Place for Your Money?
How Companies Can Succeed in AI Winter: Jeff Kagan
Utility Investing Is a Steady, Buy-and-Hold Play. Just Not in This Market
Why Nuclear Energy Is Now Part of The Road to Renewables
Our Inflation Nightmare Will Flatline in Six Months
California Wants 100% Electric Vehicles By 2035. Will Its Energy Grid Be Ready?

Market Movers

Sponsored Financial Content